A resolution designating November 2024 as "American Diabetes Month".
Latest Action
Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S6639-6640; text: CR S6637)
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™Senate Resolution 899 of the 118th Congress designates November 2024 as "American Diabetes Month." The resolution was introduced and agreed to in the Senate by unanimous consent without amendment or debate. It is a symbolic measure intended to raise awareness about diabetes during the designated month. The resolution does not include any legislative provisions, funding, or regulatory changes.
S.Res. 899 is a nonbinding Senate resolution recognizing November 2024 as American Diabetes Month to promote awareness of diabetes, passed unanimously but has since expired without further legislative action.
- The resolution officially designates November 2024 as American Diabetes Month.
- It was agreed to in the Senate by unanimous consent without amendments or debate.
- The resolution is symbolic and does not create binding law or allocate funding.
['Individuals living with diabetes and their families', 'Health advocacy organizations focused on diabetes', 'Public health agencies promoting diabetes awareness']
['No direct implementation or enforcement mechanisms are included.', 'The resolution does not allocate funding for diabetes programs or research.', 'As a symbolic measure, it relies on voluntary actions by organizations and agencies.']
The resolution was introduced and passed in the Senate during the 118th Congress as a nonbinding expression of support for diabetes awareness. Such resolutions are common for recognizing health observances and typically do not require extensive legislative debate or committee consideration.
No hidden impact flags detected
GovScope reviewed 3 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['Increased public awareness of diabetes during November 2024 may lead to greater community engagement and support for diabetes-related programs.', 'Health organizations may use the designation to promote educational campaigns and fundraising efforts.', 'Potentially increased visibility for diabetes research and prevention initiatives through voluntary activities.']
As a nonbinding Senate resolution without funding or regulatory provisions, S.Res. 899 primarily serves a symbolic role. Transparency considerations focus on ensuring the public understands the resolution does not create legal obligations or new programs. Oversight is minimal given the lack of implementation requirements.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.